Imunon, Inc. (IMNN): Cash & Equivalents
$8.78M
As of 2025-12-31
$6.86M
As of 2026-06-30
-8.6%
3-year compound annual growth
-12.5%
5-year compound annual growth
-0.5%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.78M | +49.5% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $5.87M | +0.6% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $5.84M | -49.2% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $11.49M | -41.3% | 2024-03-28, Balance as of period end |
| 2021-12-31 | $19.59M | +14.1% | 2023-03-30, Balance as of period end |
| 2020-12-31 | $17.16M | +149.7% | 2022-03-31, Balance as of period end |
| 2019-12-31 | $6.88M | -48.5% | 2021-03-19, Balance as of period end |
| 2018-12-31 | $13.35M | +16.7% | 2020-03-25, Balance as of period end |
| 2017-12-31 | $11.44M | +336.1% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $2.62M | -71.7% | 2018-03-27, Balance as of period end |
| 2015-12-31 | $9.27M | -27.0% | 2017-03-24, Balance as of period end |
| 2014-12-31 | $12.69M | +121.9% | 2016-03-30, Balance as of period end |
| 2013-12-31 | $5.72M | -61.9% | 2016-03-30, Balance as of period end |
| 2012-12-31 | $14.99M | -25.6% | 2015-03-12, Balance as of period end |
| 2011-12-31 | $20.15M | n/m | 2014-03-13, Balance as of period end |
| 2010-12-31 | $1.14M | n/a | 2013-03-18, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Imunon, Inc. (IMNN) | 2025-12-31 | $8.78M | +49.5% |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | $4.03M | +708.3% |
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | $11.63M | +275.8% |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | $3.12M | -26.7% |
| PMGC Holdings Inc. (ELAB) | 2024-12-31 | $3.98M | +19.8% |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | $7.80M | +440.3% |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | $10.70M | +64.6% |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | $5.00M | n/a |
| NewcelX Ltd. (NCEL) | 2025-12-31 | $2.20M | +238.6% |
Compare IMNN, TTRX, ANEB, PRFX side by side · Screen every company in Pharmaceutical Preparations ↗